What Does TRT Cost? A Transparent Pricing Guide

The cost of TRT (testosterone replacement therapy) in the United States generally falls anywhere from around $20 per month for the least-expensive injections to several hundred dollars or more, depending on three main factors: which modality you use, the labs and visits your provider requires, and whether you pay cash or bill insurance. Every dollar figure below is general US market context drawn from consumer pharmacy-pricing sources, not Revive pricing, and every real-world quote is provider-determined after an evaluation. For current Revive figures, see our pricing page.

What actually drives the cost of TRT?

Three levers explain almost the entire spread you will see quoted online. First, the formulation: injectable testosterone cypionate is usually the cheapest, topical gels sit in the middle, and implanted pellets cost the most because they add a procedure fee. Second, the mandatory clinical workup and ongoing monitoring required by guidelines. Third, the pay model, cash-pay telehealth versus insurance, which changes both the sticker price and what hoops you jump through.

It helps to understand why monitoring is not optional. Testosterone is a Schedule III controlled substance, placed there by the Anabolic Steroids Control Act of 1990. That legal status is the structural reason you cannot simply buy or refill it: it requires a prescription, a diagnosis, and provider oversight. (For more, see our explainer on whether testosterone is a controlled substance.)

How much do the different TRT modalities cost?

The modality you and your provider choose is the single biggest line item. The table below collects general US cash-pay ranges from consumer pricing aggregators. These are not clinical facts and are not Revive pricing; treat them as ballparks that vary by brand, dose, and pharmacy.

Modality	General US cash-pay range (not Revive pricing)	Why
Injections (testosterone cypionate)	About $109 for a two-vial one-month supply (one injection every two weeks) per SingleCare; a telehealth aggregator cites a range of $20-$100/month per Hims	Typically the least-expensive route; generic and self-administered.
Topical gels/creams	Commonly cited around $400-$1,000/month for gels and creams per SingleCare	Branded formulations and daily dosing raise the price.
Pellets (implanted)	Testopel cited at about $1,307 for 10 (75 mg) pellets without insurance per SingleCare	A clinician-performed insertion fee is added on top of medication.

One telehealth aggregator brackets the whole picture as anywhere from as little as $20/month for injections to more than $1,000 per pellet insertion (Hims); a separate consumer pharmacy source cites an average of $100-$450 per month without insurance (SingleCare). The takeaway is not a single number but a wide spread driven mostly by modality. If you want to understand dosing differences behind these formulations, our TRT dosage guide walks through the basics.

Why do labs and monitoring add to the price?

TRT is not a one-and-done purchase. Diagnosis and monitoring are built into responsible care, and they carry recurring costs. The Endocrine Society Clinical Practice Guideline (2018) recommends diagnosing hypogonadism only in men who have both symptoms and unequivocally low testosterone, confirmed by measuring total testosterone on two separate mornings while fasting. That two-test workup is a baseline cost every legitimate TRT path incurs.

Once you start, monitoring continues. The Endocrine Society advises tracking symptoms, serum testosterone, and hematocrit, and assessing prostate cancer risk before starting and again 3-12 months after. The AUA guideline (Table 7) is more specific: total testosterone at 2-4 weeks after initiation, then every 6-12 months when stable; hemoglobin/hematocrit at baseline and every 6-12 months to keep hematocrit below 54 percent; and PSA in testosterone-deficient patients over 40. On top of that, the FDA’s February 28, 2025 class-wide labeling change added a warning that all testosterone products can increase blood pressure, making blood-pressure checks an FDA-flagged safety step.

What does that recurring panel cost? In the general US direct-access (cash-pay) lab market, a bundled TRT panel (testosterone + CBC + CMP + PSA) runs about $76, inclusive of an $18 requisition charge (FindLabTest); comprehensive hormone panels can run higher without insurance. Monitoring frequency and the exact panel are provider-determined, and these are general market figures, not Revive pricing.

Cash-pay telehealth vs. insurance: which is cheaper?

This depends heavily on your situation. Cash-pay telehealth bundles fold the visit, prescription, and sometimes labs into a transparent monthly figure. Insurance can lower your out-of-pocket cost but adds requirements. According to one consumer source, insurers typically require a documented diagnosis (symptoms plus low morning testosterone, often below 300 ng/dL on two separate draws) and may require prior authorization, commonly 3-7 business days (Doctronic). Formularies often favor generic testosterone cypionate injections over branded gels or patches, which can trigger higher copays or step therapy.

That below-300 ng/dL, two-morning-draw threshold is not just an insurance quirk; it tracks the clinical standard. The Endocrine Society and AUA both anchor diagnosis to low morning testosterone, and the TRAVERSE trial enrolled men with two fasting testosterone levels below 300 ng/dL. For a deeper look at coverage mechanics, see is TRT covered by insurance.

How do safety and monitoring shape the value question?

Cost is not just price; it is price relative to a monitored therapy with real, not guaranteed, outcomes. The TRAVERSE trial (NEJM 2023) randomized 5,246 hypogonadal men aged 45-80 with high cardiovascular risk and followed them about 33 months. Testosterone (a 1.62% transdermal gel) was non-inferior to placebo for major adverse cardiac events (hazard ratio 0.96; 95% CI 0.78-1.17; 7.0% vs. 7.3%), but the testosterone group had more atrial fibrillation, acute kidney injury, and pulmonary embolism. The 2025 FDA action reflected this: it removed the cardiovascular boxed warning while adding the blood-pressure warning. The 2025 change did not make testosterone safe for everyone or endorse it for aging.

On indications, FDA-approved testosterone products are approved only as replacement therapy for hypogonadism due to a medical condition; benefit and safety are not established for low testosterone caused by aging. Because of all this, the cheapest modality is not automatically the appropriate one, the right choice and the total cost are provider-determined after evaluation, and individual results vary. If you are still deciding whether testosterone is the right path at all, compare it with enclomiphene vs. TRT.

Where does hCG fit into TRT cost?

Some men add hCG (human chorionic gonadotropin) to a TRT protocol for fertility or testicular preservation, which can be an extra cost line. Access to compounded hCG has narrowed since a 2020 FDA mandate (PMC10083688). hCG is FDA-approved for hypogonadotropic hypogonadism; its use alongside TRT to preserve fertility or testicular function is not an FDA-approved indication, and in that setting it is prescribed on a patient-specific basis by a licensed provider. Compounded products are not FDA-approved and the FDA has not evaluated them for safety, quality, or efficacy. We mention it only because it can change your bill; it is not a protocol recommendation. For background, see hCG with TRT.

Frequently asked questions

What is the average cost of TRT per month?

In the general US cash-pay market, one consumer pharmacy source cites an average of roughly $100-$450 per month without insurance (SingleCare), while a telehealth aggregator cites injections at $20-$100 per month (Hims), with branded gels and pellets running higher. These figures are general market context, not Revive pricing, are framed as ranges, and are provider-determined; individual results vary. See our pricing page for current Revive figures.

Why does TRT require ongoing lab tests and visits?

Testosterone is a Schedule III controlled substance that requires a diagnosis and oversight. The Endocrine Society and AUA recommend recurring monitoring of testosterone, hematocrit, and PSA (often every 6-12 months when stable), and the FDA’s 2025 labeling change added blood-pressure monitoring. These guideline-required labs and visits are why TRT carries unavoidable recurring costs beyond the medication itself.

Are injections really cheaper than gels or pellets?

According to consumer pricing sources, yes, generic testosterone cypionate injections are typically the least-expensive modality (a telehealth aggregator cites $20-$100/month per Hims, and SingleCare cites about $109 for a two-vial one-month supply), gels are higher, and pellets are highest because they add a clinician-performed insertion fee. The cheapest option is not automatically the appropriate one; the right modality is provider-determined after evaluation.

Does insurance cover TRT?

It can, but insurers generally require a documented diagnosis (symptoms plus low morning testosterone, often below 300 ng/dL on two separate draws) and may require prior authorization, commonly 3-7 business days (Doctronic). Formularies often favor generic injectable cypionate over branded gels or patches. Coverage and out-of-pocket cost vary by plan; check our coverage explainer and confirm details with your insurer.

How much do TRT monitoring labs cost on their own?

In the general US direct-access lab market, a bundled TRT panel (testosterone, CBC, CMP, PSA) runs about $76, inclusive of an $18 requisition charge (FindLabTest), with comprehensive hormone panels potentially higher without insurance. These are general market estimates, not Revive pricing, and frequency is provider-determined.

Is the cheapest TRT option the best choice?

Not necessarily. Because TRT requires diagnosis and ongoing monitoring, and because the TRAVERSE trial showed real risks (more atrial fibrillation, acute kidney injury, and pulmonary embolism even where cardiac events were non-inferior to placebo), the appropriate modality and total cost are best determined by a licensed provider after evaluation. Individual results vary.